Transforming type 1 diabetes: the next wave of innovation

A global perspective on the issue of access to insulin

(2021) David Beran et al.   DIABETOLOGIA

The promise of stem cell-derived islet replacement therapy

(2021) Douglas Melton   DIABETOLOGIA

The consequences of hypoglycaemia

(2021) Stephanie A. Amiel   DIABETOLOGIA

New closed-loop insulin systems

(2021) Charlotte K. Boughton et al.   DIABETOLOGIA

Realising the long-term promise of insulin therapy: the DCCT/EDIC study

(2021) David M. Nathan   DIABETOLOGIA

Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes: the randomised, head-to-head CONCLUDE trial

(2020) Athena Philis-Tsimikas et al.   DIABETOLOGIA

GLP-1 receptor agonists synergize with DYRK1A inhibitors to potentiate functional human β cell regeneration

(2020) Courtney Ackeifi et al.   Science Translational Medicine

A combined risk score enhances prediction of type 1 diabetes among susceptible children

(2020) Lauric A. Ferrat et al.   NATURE MEDICINE

Solving the Puzzle of Immune Tolerance for β-Cell Replacement Therapy for Type 1 Diabetes

(2020) Jeffrey A. Bluestone et al.   Cell Stem Cell

The Pathological Evolution of Glucose Response Curves During the Progression to Type 1 Diabetes in the TrialNet Pathway to Prevention Study

(2020) Heba M. Ismail et al.   DIABETES CARE

Dynamics of Islet Autoantibodies During Prospective Follow-Up From Birth to Age 15 Years

(2020) Petra M Pöllänen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment

(2020) Julio Rosenstock et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sensory processing and cortisol at age 4 years: Procedural pain‐related stress in children born very preterm

(2020) Mia A. McLean et al.   DEVELOPMENTAL PSYCHOBIOLOGY

Progress in Translational Regulatory T Cell Therapies for Type 1 Diabetes and Islet Transplantation

(2020) Braulio A Marfil-Garza et al.   ENDOCRINE REVIEWS

The Lancet Commission on diabetes: using data to transform diabetes care and patient lives

(2020) Juliana C N Chan et al.   LANCET

Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes

(2020) Teresa Quattrin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial

(2019) Inge B Halberg et al.   Lancet Diabetes & Endocrinology

An ingestible self-orienting system for oral delivery of macromolecules

(2019) Alex Abramson et al.   SCIENCE

An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes

(2019) Kevan C. Herold et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hypoglycaemia is reduced with use of inhaled Technosphere ® Insulin relative to insulin aspart in type 1 diabetes mellitus

(2019) E. R. Seaquist et al.   DIABETIC MEDICINE

Advances in oral peptide therapeutics

(2019) Daniel J. Drucker   NATURE REVIEWS DRUG DISCOVERY

Linking a cell-division gene and a suicide gene to define and improve cell therapy safety

(2018) Qin Liang et al.   NATURE

Residual Insulin Production and Pancreatic  -Cell Turnover After 50 Years of Diabetes: Joslin Medalist Study

(2010) H. A. Keenan et al.   DIABETES